User profiles for B. F. Kimler
Bruce KimlerVerified email at kumc.edu Cited by 8414 |
[HTML][HTML] Omega-3 fatty acids for breast cancer prevention and survivorship
CJ Fabian, BF Kimler, SD Hursting - Breast cancer research, 2015 - Springer
Women with evidence of high intake ratios of the marine omega-3 fatty acids eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA) relative to the omega-6 arachidonic acid …
acid (EPA) and docosahexaenoic acid (DHA) relative to the omega-6 arachidonic acid …
[PDF][PDF] Selective estrogen-receptor modulators for primary prevention of breast cancer
CJ Fabian, BF Kimler - Journal of Clinical Oncology, 2005 - stati34521.narod.ru
Depending on their structure and context, SERMs differentially modify expression of multiple
genes whose transcription is regulated by activated ER. 2, 3 A SERM’s geneand tissue-…
genes whose transcription is regulated by activated ER. 2, 3 A SERM’s geneand tissue-…
[HTML][HTML] Breast-tissue sampling for risk assessment and prevention
Breast tissue and duct fluid provide a rich source of biomarkers to both aid in the assessment
of short-term risk of developing breast cancer and predict and assess responses to …
of short-term risk of developing breast cancer and predict and assess responses to …
Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer
Vitamin D deficiency and insufficiency may contribute to musculoskeletal symptoms and
bone loss observed in women taking aromatase inhibitors (AIs). This study was conducted to …
bone loss observed in women taking aromatase inhibitors (AIs). This study was conducted to …
Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model
CJ Fabian, BF Kimler, CM Zalles… - Journal of the …, 2000 - academic.oup.com
Background: Biomarkers are needed to refine short-term breast cancer risk estimates from
epidemiologic models and to measure response to prevention interventions. The purpose of …
epidemiologic models and to measure response to prevention interventions. The purpose of …
Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing
NCCN guidelines recommend genetic testing for all triple-negative breast cancer (TNBC)
patients aged ≤60 years. However, due to the lack of prospective information in unselected …
patients aged ≤60 years. However, due to the lack of prospective information in unselected …
Efficacy of neoadjuvant carboplatin plus docetaxel in triple-negative breast cancer: combined analysis of two cohorts
Purpose: Recent studies demonstrate that addition of neoadjuvant (NA) carboplatin to
anthracycline/taxane chemotherapy improves pathologic complete response (pCR) in triple-…
anthracycline/taxane chemotherapy improves pathologic complete response (pCR) in triple-…
L-Ascorbic acid induces apoptosis in acute myeloid leukemia cells via hydrogen peroxide-mediated mechanisms
…, CW Jung, K Park, HD Riordan, BF Kimler… - … International Journal of …, 2004 - Elsevier
l-Ascorbic acid (LAA) is being investigated clinically for the treatment of patients with acute
myeloid leukemia (AML) based on the observed effects of LAA on AML progenitor cells in vitro…
myeloid leukemia (AML) based on the observed effects of LAA on AML progenitor cells in vitro…
Pathological response and survival in triple-negative breast cancer following neoadjuvant carboplatin plus docetaxel
…, AP O'Dea, J Heldstab, RA Jensen, BF Kimler… - Clinical Cancer …, 2018 - AACR
Purpose: Prognostic value of pathologic complete response (pCR) and extent of pathologic
response attained with anthracycline-free platinum plus taxane neoadjuvant chemotherapy (…
response attained with anthracycline-free platinum plus taxane neoadjuvant chemotherapy (…
A phase II breast cancer chemoprevention trial of oral α-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers
… Klemp J., Brady D., Kimler B., Fabian CJ Incidence of BRCA1/2 germ line alterations in a high
… Fabian CJ, Kamel S., Zalles CM, Kimler BF Identification of a chemoprevention cohort from …
… Fabian CJ, Kamel S., Zalles CM, Kimler BF Identification of a chemoprevention cohort from …